S Stürzebecher

714 total citations
18 papers, 587 citations indexed

About

S Stürzebecher is a scholar working on Pharmacology, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, S Stürzebecher has authored 18 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 5 papers in Pathology and Forensic Medicine and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in S Stürzebecher's work include Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Multiple Sclerosis Research Studies (4 papers) and Inflammatory mediators and NSAID effects (4 papers). S Stürzebecher is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Multiple Sclerosis Research Studies (4 papers) and Inflammatory mediators and NSAID effects (4 papers). S Stürzebecher collaborates with scholars based in United States, Germany and Netherlands. S Stürzebecher's co-authors include Jürgen F. Heubach, Johanna M. Beekman, Susanne Schwenke, Joachim Reischl, Ulrich Mrowietz, W. Witt, Roland Martinꝉ, Joseph A. Frank, Henry F. McFarland and Andreas Rosenwald and has published in prestigious journals such as Brain, Journal of Investigative Dermatology and Journal of Neuroimmunology.

In The Last Decade

S Stürzebecher

17 papers receiving 545 citations

Peers

S Stürzebecher

PFM

IMMUN

ONCOL

RHEUM

Gary A. Zimmerman United States

Satoshi Takabuchi Japan

Ann Chernosky United States

Anne M. Skoff United States

Zhiyong Wu China

Debra Tompson United Kingdom

Tao Bai China

Jun Zheng China

Seiko Oda Japan

Gary A. Zimmerman United States

S Stürzebecher

43 ×0.2

PFM

191 ×1.1

IMMUN

160 ×1.0

133 ×0.9

ONCOL

17 ×0.2

RHEUM

Citations per year, relative to S Stürzebecher S Stürzebecher (= 1×) peers Gary A. Zimmerman

Countries citing papers authored by S Stürzebecher

Since Specialization

Citations

This map shows the geographic impact of S Stürzebecher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Stürzebecher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Stürzebecher more than expected).

Fields of papers citing papers by S Stürzebecher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Stürzebecher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Stürzebecher. The network helps show where S Stürzebecher may publish in the future.

Co-authorship network of co-authors of S Stürzebecher

This figure shows the co-authorship network connecting the top 25 collaborators of S Stürzebecher. A scholar is included among the top collaborators of S Stürzebecher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Stürzebecher. S Stürzebecher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Riemsma, Rob, Carol Forbes, Julie Harker, et al.. (2011). Systematic review of tapentadol in chronic severe pain. Current Medical Research and Opinion. 27(10). 1907–1930. 67 indexed citations

Hilpert, Jan, Johanna M. Beekman, Susanne Schwenke, et al.. (2008). Biological response genes after single dose administration of interferon β-1b to healthy male volunteers. Journal of Neuroimmunology. 199(1-2). 115–125. 13 indexed citations

Reischl, Joachim, Susanne Schwenke, Johanna M. Beekman, et al.. (2006). Increased Expression of Wnt5a in Psoriatic Plaques. Journal of Investigative Dermatology. 127(1). 163–169. 132 indexed citations

Rieckmann, Peter, Niels Kruse, Lex Nagelkerken, et al.. (2005). Soluble vascular cell adhesion molecule (VCAM) is associated with treatment effects of Interferon beta-1b in patients with Secondary Progressive Multiple Sclerosis. Journal of Neurology. 252(5). 526–533. 11 indexed citations

Stürzebecher, S, Klaus‐Peter Wandinger, Andreas Rosenwald, et al.. (2003). Expression profiling identifies responder and non‐responder phenotypes to interferon‐β in multiple sclerosis. Brain. 126(6). 1419–1429. 146 indexed citations

Schmidt, Jens, S Stürzebecher, Klaus V. Toyka, & Ralf Gold. (2001). Interferon‐β treatment of experimental autoimmune encephalomyelitis leads to rapid nonapoptotic termination of T cell infiltration. Journal of Neuroscience Research. 65(1). 59–67. 21 indexed citations

Stürzebecher, S, et al.. (1999). Pharmacodynamic Comparison of Single Doses of IFN-beta 1a and IFN-beta 1b in Healthy Volunteers. Journal of Interferon & Cytokine Research. 19(11). 1257–1264. 63 indexed citations

Schillinger, E., et al.. (1991). Effects of prostacyclin analogues in in vivo tumor models.. PubMed. 21B. 901–8. 10 indexed citations

Stürzebecher, S, et al.. (1989). Effects of PGD2, PGE1, and PGI2-analogues on PGDF-release and aggregation of human gelfiltered platelets.. PubMed. 301. 365–9. 5 indexed citations

10.

Stürzebecher, S, et al.. (1989). Myocardial ischaemia and reperfusion in the anaesthetised pig: reduction of infarct size and myocardial enzyme release by the stable prostacyclin analogue iloprost.. PubMed. 301. 155–9. 3 indexed citations

11.

Stürzebecher, S, et al.. (1989). ZK 110 841--a selective and potent prostaglandin D2 analogue.. PubMed. 301. 597–601. 1 indexed citations

12.

Stürzebecher, S, et al.. (1988). Platelet inhibitory and haemodynamic effects of a new stable PGI2 analogue, cicaprost (ZK 96480), in different animal species and in man.. PubMed. 47(10-11). S45–7. 10 indexed citations

13.

Stürzebecher, S & W. Witt. (1988). The PGI2-analogue iloprost and the TXA2-receptor antagonist sulotroban synergistically inhibit TXA2-dependent platelet activation. Prostaglandins. 36(6). 751–760. 11 indexed citations

14.

Witt, W., et al.. (1988). Synergistic antiplatelet and antithrombotic effects of a prostacyclin analogue (iloprost) combined with a thromboxane antagonist (sulotroban) in guinea pigs and rats. Thrombosis Research. 51(6). 607–616. 10 indexed citations

15.

Stürzebecher, S, et al.. (1988). Potential therapeutic mechanisms of stable prostacyclin (PGI2)-mimetics in severe peripheral vascular disease.. PubMed. 47(10-11). S40–4. 10 indexed citations

16.

Stürzebecher, S, et al.. (1988). Potential therapeutic mechanisms of stable prostacyclin (PGI2)-mimetics in severe peripheral vascular disease. Pharmacological Research Communications. 20. 259–259. 4 indexed citations

17.

Stürzebecher, S, Martin Haberey, E. Schillinger, et al.. (1986). Pharmacological profile of a novel carbacyclin derivative with high metabolic stability and oral activity in the rat. Prostaglandins. 31(1). 95–109. 63 indexed citations

18.

Stürzebecher, S, et al.. (1984). Antifibrillatory action of the stable orally active prostacyclin analogues iloprost and ZK 96 480 in rats after coronary artery ligation.. PubMed. 43(8-9). S175–8. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact